Angelico, G.; Mazzucchelli, M.; Attanasio, G.; Tinnirello, G.; Farina, J.; Zanelli, M.; Palicelli, A.; Bisagni, A.; Barbagallo, G.M.V.; Certo, F.;
et al. H3K27me3 Loss in Central Nervous System Tumors: Diagnostic, Prognostic, and Therapeutic Implications. Cancers 2024, 16, 3451.
https://doi.org/10.3390/cancers16203451
AMA Style
Angelico G, Mazzucchelli M, Attanasio G, Tinnirello G, Farina J, Zanelli M, Palicelli A, Bisagni A, Barbagallo GMV, Certo F,
et al. H3K27me3 Loss in Central Nervous System Tumors: Diagnostic, Prognostic, and Therapeutic Implications. Cancers. 2024; 16(20):3451.
https://doi.org/10.3390/cancers16203451
Chicago/Turabian Style
Angelico, Giuseppe, Manuel Mazzucchelli, Giulio Attanasio, Giordana Tinnirello, Jessica Farina, Magda Zanelli, Andrea Palicelli, Alessandra Bisagni, Giuseppe Maria Vincenzo Barbagallo, Francesco Certo,
and et al. 2024. "H3K27me3 Loss in Central Nervous System Tumors: Diagnostic, Prognostic, and Therapeutic Implications" Cancers 16, no. 20: 3451.
https://doi.org/10.3390/cancers16203451
APA Style
Angelico, G., Mazzucchelli, M., Attanasio, G., Tinnirello, G., Farina, J., Zanelli, M., Palicelli, A., Bisagni, A., Barbagallo, G. M. V., Certo, F., Zizzo, M., Koufopoulos, N., Magro, G., Caltabiano, R., & Broggi, G.
(2024). H3K27me3 Loss in Central Nervous System Tumors: Diagnostic, Prognostic, and Therapeutic Implications. Cancers, 16(20), 3451.
https://doi.org/10.3390/cancers16203451
